263 related articles for article (PubMed ID: 34439804)
1. Phytoplankton of the Curonian Lagoon as a New Interesting Source for Bioactive Natural Products. Special Impact on Cyanobacterial Metabolites.
Overlingė D; Toruńska-Sitarz A; Cegłowska M; Błaszczyk A; Szubert K; Pilkaitytė R; Mazur-Marzec H
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439804
[TBL] [Abstract][Full Text] [Related]
2. Cyanobacteria and Eukaryotic Microalgae as Emerging Sources of Antibacterial Peptides.
Rojas V; Rivas L; Cárdenas C; Guzmán F
Molecules; 2020 Dec; 25(24):. PubMed ID: 33316949
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of exposure to microcystins in the scum of the filamentous cyanobacterium Aphanizomenon flos-aquae accumulated on the western shoreline of the Curonian Lagoon.
Šulčius S; Pilkaitytė R; Mazur-Marzec H; Kasperovičienė J; Ezhova E; Błaszczyk A; Paškauskas R
Mar Pollut Bull; 2015 Oct; 99(1-2):264-70. PubMed ID: 26234611
[TBL] [Abstract][Full Text] [Related]
4. Dereplication of Natural Products with Antimicrobial and Anticancer Activity from Brazilian Cyanobacteria.
Shishido TK; Popin RV; Jokela J; Wahlsten M; Fiore MF; Fewer DP; Herfindal L; Sivonen K
Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31878347
[TBL] [Abstract][Full Text] [Related]
5. Overview of key phytoplankton toxins and their recent occurrence in the North and Baltic Seas.
Luckas B; Dahlmann J; Erler K; Gerdts G; Wasmund N; Hummert C; Hansen PD
Environ Toxicol; 2005 Feb; 20(1):1-17. PubMed ID: 15712332
[TBL] [Abstract][Full Text] [Related]
6. Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.
Tan LT; Phyo MY
Molecules; 2020 May; 25(9):. PubMed ID: 32397127
[TBL] [Abstract][Full Text] [Related]
7. Cyanobacteria--a potential source of new biologically active substances.
Kreitlow S; Mundt S; Lindequist U
J Biotechnol; 1999 Apr; 70(1-3):61-3. PubMed ID: 10412206
[TBL] [Abstract][Full Text] [Related]
8. Bioprospecting microalgae and cyanobacteria for biopharmaceutical applications.
Saeed MU; Hussain N; Shahbaz A; Hameed T; Iqbal HMN; Bilal M
J Basic Microbiol; 2022 Sep; 62(9):1110-1124. PubMed ID: 34914840
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory Activity of Bioactive Compounds from Microalgae and Cyanobacteria by Focusing on the Mechanisms of Action.
Tabarzad M; Atabaki V; Hosseinabadi T
Mol Biol Rep; 2020 Aug; 47(8):6193-6205. PubMed ID: 32557174
[TBL] [Abstract][Full Text] [Related]
10. Are there concerns regarding cHAB in coastal bathing waters affected by freshwater-brackish continuum?
Overlingė D; Kataržytė M; Vaičiūtė D; Gyraite G; Gečaitė I; Jonikaitė E; Mazur-Marzec H
Mar Pollut Bull; 2020 Oct; 159():111500. PubMed ID: 32736200
[TBL] [Abstract][Full Text] [Related]
11. Chemistry and biology of kahalalides.
Gao J; Hamann MT
Chem Rev; 2011 May; 111(5):3208-35. PubMed ID: 21480581
[No Abstract] [Full Text] [Related]
12. Structural Diversity, Biological Properties and Applications of Natural Products from Cyanobacteria. A Review.
Shah SAA; Akhter N; Auckloo BN; Khan I; Lu Y; Wang K; Wu B; Guo YW
Mar Drugs; 2017 Nov; 15(11):. PubMed ID: 29125580
[TBL] [Abstract][Full Text] [Related]
13. Biodiversity, Bioactivity, and Metabolites of High Desert Derived Oregonian Soil Bacteria.
Zhu C; Lew CI; Neuhaus GF; Adpressa DA; Zakharov LN; Kaweesa EN; Plitzko B; Loesgen S
Chem Biodivers; 2021 Apr; 18(4):e2100046. PubMed ID: 33636028
[TBL] [Abstract][Full Text] [Related]
14. Immense essence of excellence: marine microbial bioactive compounds.
Bhatnagar I; Kim SK
Mar Drugs; 2010 Oct; 8(10):2673-701. PubMed ID: 21116414
[TBL] [Abstract][Full Text] [Related]
15. Bioactive natural products from marine cyanobacteria for drug discovery.
Tan LT
Phytochemistry; 2007 Apr; 68(7):954-79. PubMed ID: 17336349
[TBL] [Abstract][Full Text] [Related]
16. Hot moments and hotspots of cyanobacteria hyperblooms in the Curonian Lagoon (SE Baltic Sea) revealed via remote sensing-based retrospective analysis.
Vaičiūtė D; Bučas M; Bresciani M; Dabulevičienė T; Gintauskas J; Mėžinė J; Tiškus E; Umgiesser G; Morkūnas J; De Santi F; Bartoli M
Sci Total Environ; 2021 May; 769():145053. PubMed ID: 33736231
[TBL] [Abstract][Full Text] [Related]
17. Portobelamides A and B and Caciqueamide, Cytotoxic Peptidic Natural Products from a
Demirkiran O; Almaliti J; Leão T; Navarro G; Byrum T; Valeriote FA; Gerwick L; Gerwick WH
J Nat Prod; 2021 Aug; 84(8):2081-2093. PubMed ID: 34269583
[TBL] [Abstract][Full Text] [Related]
18. Cyanobacteria and microalgae bioactive compounds in skin-ageing: potential to restore extracellular matrix filling and overcome hyperpigmentation.
Favas R; Morone J; Martins R; Vasconcelos V; Lopes G
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1829-1838. PubMed ID: 34353202
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial and antibiotic potentiating activities of tropical marine sponge extracts.
Beesoo R; Bhagooli R; Neergheen-Bhujun VS; Li WW; Kagansky A; Bahorun T
Comp Biochem Physiol C Toxicol Pharmacol; 2017 Jun; 196():81-90. PubMed ID: 28392375
[TBL] [Abstract][Full Text] [Related]
20. Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals.
Suarez-Jimenez GM; Burgos-Hernandez A; Ezquerra-Brauer JM
Mar Drugs; 2012 May; 10(5):963-986. PubMed ID: 22822350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
